Information;Order — ECLI:EU:C:2021:521
Date: 2021-06-24
Language of the case: English
Subject matter: Procedural provisions
Procedure: Action for annulment;Appeal;Application to intervene - unfounded

Order of the Vice-President of the Court of 24 June 2021 – ratiopharm and Others v Commission (Case C‑220/21 P(I)) (Appeal – Intervention – Second paragraph of Article 40 of the Statute of the Court of Justice of the European Union – Interest in the result of the case – Public health – Medicinal products for human use – Regulation (EC) No 726/2004 – Directive 2001/83/EC – Decision granting marketing authorisation for the medicinal product for human use Dexmedetomidine Accord – dexmedetomidine – Dismissal) Judicial proceedings – Intervention – Admissibility criteria – Interest in the result of the case – Concept – Need for a direct and existing interest – Interest which must lead to a solution to the dispute such as to affect the legal position of the applicant (Statute of the Court of Justice, Art. 40, para. 2) (see paras 17-24) Operative part 1. The appeal is dismissed. 2. ratiopharm GmbH, Teva Pharma – Produtos Farmaceuticos Lda, Teva Danmark A/S, Teva Sweden AB and Teva Nederland BV, as well as Orion Oyj and the European Commission, shall bear their own costs.